Y-box protein-1 is a transcriptional regulator of BMP7

Journal of Cellular Biochemistry

Volumn 112, Issue 4, 2011, Pages 1130-1137

  Wang, Shinong ^a   Hirschberg, Raimund ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

BMP7; Diabetic nephropathy; Fibrogenesis; TGF ; Transcriptional activation

Indexed keywords

DNA BINDING PROTEIN; GLUCOSE; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; Y BOX PROTEIN 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN; CELLULAR DISTRIBUTION; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 7; CELL LINE; COLD SHOCK PROTEINS AND PEPTIDES; DOGS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GLUCOSE; MOLECULAR SEQUENCE DATA; PEPTIDES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA INTERFERENCE; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 79952567915     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23027     Document Type: Article

References (33)

1. Balmer JE, Blomhoff R. 2002. Gene expression regulation by retinoic acid. J Lipid Res 43:1773-1808. (Pubitemid 35315797)
2. Bosukonda D, Shih MS, Sampath KT, Vukicevic S. 2000. Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys. Kidney Int 58:1902-1911.
3. Didier DK, Schiffenbauer J, Woulfe SL, Zacheis M, Schwartz BD. 1988. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci USA 85:7322-7326.
4. Dudley AT, Lyons KM, Robertson EJ. 1995. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807.
5. En-Nia A, Yilmaz E, Klinge U, Lovett DH, Stefanidis I, Mertens PR. 2005. Transcription factor YB-1 mediates DNA polymerase alpha gene expression. J Biol Chem 280:7702-7711. (Pubitemid 40349663)
6. Evdokimova V, Ovchinnikov LP, Sorensen PH. 2006. Y-box binding protein 1: providing a new angle on translational regulation. Cell Cycle 5:1143-1147. (Pubitemid 43845371)
7. Finkbeiner MR, Astanehe A, To K, Fotovati A, Davies AH, Zhao Y, Jiang H, Stratford AL, Shadeo A, Boccaccio C, Comoglio P, Mertens PR, Eirew P, Raouf A, Eaves CJ, Dunn SE. 2009. Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells. Oncogene 28:1421-1431.
8. Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J. 2000. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279:F130-143.
9. Jurchott K, Bergmann S, Stein U, Walther W, Janz M, Manni I, Piaggio G, Fietze E, Dietel M, Royer HD. 2003. YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J Biol Chem 278:27988-27996. (Pubitemid 36899994)
10. Kawai S, Sugiura T. 2001. Characterization of human bone morphogenetic protein (BMP)-4 and -7 gene promoters: activation of BMP promoters by Gli, a sonic hedgehog mediator. Bone 29:54-61. (Pubitemid 32707923)
11. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74:5383-5392. (Pubitemid 35215372)
12. Kolluri R, Torrey TA, Kinniburgh AJ. 1992. A CT promoter element binding protein: definition of a double-strand and a novel single-strand DNA binding motif. Nucleic Acids Res 20:111-116.
13. Mitu GM, Wang S, Hirschberg R. 2007. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol Renal Physiol 293:F1641-F1648. (Pubitemid 350086001)
14. Monroe DG, Jin DF, Sanders MM. 2000. Estrogen opposes the apoptotic effects of bone morphogenetic protein 7 on tissue remodeling. Mol Cell Biol 20:4626-4634. (Pubitemid 30396110)
15. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S. 2002. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13(Suppl. 1):S14-21.
16. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75:4646-4658. (Pubitemid 37082259)
17. Ozkaynak E, Jin DF, Jelic M, Vukicevic S, Oppermann H. 1997. Osteogenic protein-1 mRNA in the uterine endometrium. Biochem Biophys Res Commun 234:242-246. (Pubitemid 27267567)
18. Paralkar VM, Grasser WA, Mansolf AL, Baumann AP, Owen TA, Smock SL, Martinovic S, Borovecki F, Vukicevic S, Ke HZ, Thompson DD. 2002. Regulation of BMP-7 expression by retinoic acid and prostaglandin E(2). J Cell Physiol 190:207-217. (Pubitemid 34027823)
19. Raffetseder U, Frye B, Rauen T, Jurchott K, Royer HD, Jansen PL, Mertens PR. 2003. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J Biol Chem 278:18241-18248. (Pubitemid 36799442)
20. Raffetseder U, Rauen T, Djudjaj S, Kretzler M, En-Nia A, Tacke F, Zimmermann HW, Nelson PJ, Frye BC, Floege J, Stefanidis I, Weber C, Mertens PR. 2009. Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1. Kidney Int 75:185-196.
21. Skabkin MA, Evdokimova V, Thomas AA, Ovchinnikov LP. 2001. The major messenger ribonucleoprotein particle protein p50 (YB-1) promotes nucleic acid strand annealing. J Biol Chem 276:44841-44847.
22. To K, Zhao Y, Jiang H, Hu K, Wang M, Wu J, Lee C, Yokom DW, Stratford AL, Klinge U, Mertens PR, Chen CS, Bally M, Yapp D, Dunn SE. 2007. The phosphoinositide-dependent kinase- 1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl) -3-(trifluoromethyl)-1H-pyrazol-1-yl]phen yl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor. Mol Pharmacol 72:641-652. (Pubitemid 47347299)
23. Valiahdi M. 2006. The intracellular localisation of chk-YB1 protein depends on a casein kinase II consensus sequence in the C-terminal part of the protein. Fifth AACR International Conference on Frontiers in Cancer Prevention Research. Accessed January 4, 2010. http://aacrmeetingabstracts.org/cgi/content/ abstract/2006/3/A70.
24. Wang S, Hirschberg R. 2003. BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol 284:F1006-F1013. (Pubitemid 36443585)
25. Wang S, Hirschberg R. 2004. Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem 279:23200-23206. (Pubitemid 38685626)
26. Wang S, LaPage J, Hirschberg R. 2001. Loss of tubular bone morphogenetic protein-7 (BMP7) in diabetic nephropathy. J Am Soc Nephrol 12:2392-2399. (Pubitemid 33021116)
27. Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA. 2003. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63:2037-2049. (Pubitemid 36605815)
28. Wang S, de Caestecker M, Kopp JB, Mitu G, LaPage J, Hirschberg R. 2006. Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 17:2504-2512. (Pubitemid 44300966)
29. Wolffe AP. 1994. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. Bioessays 16:245-251. (Pubitemid 2073505)
30. Yang WH, Bloch DB. 2007. Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA 13:704-712. (Pubitemid 46641529)
31. Yang Q, Han B, Xie RJ, Cheng ML. 2007. Changes of bone morphogenetic protein-7 and inhibitory Smad expression in streptozotocin-induced diabetic nephropathy rat kidney. Sheng Li Xue Bao 59:190-196.
32. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. 2003. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964-968. (Pubitemid 36889942)
33. Zhang YF, Homer C, Edwards SJ, Hananeia L, Lasham A, Royds J, Sheard P, Braithwaite AW. 2003. Nuclear localization of Y-box factor YB1 requires wild-type p53. Oncogene 22:2782-2794. (Pubitemid 36609592)